Cargando…

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Background and Objectives: Few studies have reported the drug retention rate (DRR) of biologic drugs in juvenile idiopathic arthritis (JIA), and none of them has specifically investigated the DRR of interleukin (IL)-1 inhibitors on systemic JIA (sJIA). This study aims to describe IL-1 inhibitors DRR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sota, Jurgen, Insalaco, Antonella, Cimaz, Rolando, Alessio, Maria, Cattalini, Marco, Gallizzi, Romina, Maggio, Maria Cristina, Lopalco, Giuseppe, La Torre, Francesco, Fabiani, Claudia, Pardeo, Manuela, Olivieri, Alma Nunzia, Sfriso, Paolo, Salvarani, Carlo, Gaggiano, Carla, Grosso, Salvatore, Bracaglia, Claudia, De Benedetti, Fabrizio, Rigante, Donato, Cantarini, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331484/ https://www.ncbi.nlm.nih.gov/pubmed/30670972 http://dx.doi.org/10.3389/fphar.2018.01526

Ejemplares similares

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
por: Sota, Jurgen, et al.
Publicado: (2019)

Correction to: A national cohort study on pediatric Behçet’s disease: cross-sectional data from an Italian registry
por: Gallizzi, Romina, et al.
Publicado: (2018)

A national cohort study on pediatric Behçet’s disease: cross-sectional data from an Italian registry
por: Gallizzi, Romina, et al.
Publicado: (2017)

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
por: Vitale, Antonio, et al.
Publicado: (2016)

Evaluation of the disease course of Italian children with juvenile idiopathic arthritis treated with etanercept: preliminary results in 772 patients
por: Verazza, Sara, et al.
Publicado: (2014)

Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-α Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network
por: Gaggiano, Carla, et al.
Publicado: (2020)

Basic Characteristics of Adults with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenopathy Syndrome in Comparison with the Typical Pediatric Expression of Disease
por: Cattalini, Marco, et al.
Publicado: (2015)

P03-012 - A P268S NOD2 mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

P02-016 - A novel PSMB8 mutation causing candle syndrome
por: Messia, V, et al.
Publicado: (2013)

P02-031 - Phenotype of V198M and Q703K NLRP3 variants
por: Messia, V, et al.
Publicado: (2013)

PReS-FINAL-2202: A novel PSMB8 mutation associated with CANDLE syndrome
por: Insalaco, A, et al.
Publicado: (2013)

PReS-FINAL-2201: A P268S NOD mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

PReS-FINAL-2200: Phenotype of V198M and Q703K NLRP3 variants
por: Messia, V, et al.
Publicado: (2013)

Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis
por: Gentileschi, Stefano, et al.
Publicado: (2020)

P02-032 - CAPS: a novel mutation and an unusual phenotype
por: Insalaco, A, et al.
Publicado: (2013)

P01-050 – Anakinra in systemic JIA: single center experience
por: Pardeo, M, et al.
Publicado: (2013)

Predictors of relapse after discontinuing systemic treatment in autoimmune chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2014)

Cronic non-bacterial osteomyelitis (CNO) in a cohort of pediatric patients: clinical, biological and radiological response to treatment with Anakinra
por: Pardeo, M, et al.
Publicado: (2015)

Involvement of the IFN-gamma pathway in a patient with candle syndrome carrying a novel variant of PSMB8 gene
por: Insalaco, Antonella, et al.
Publicado: (2014)

An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome
por: Arduini, Alessia, et al.
Publicado: (2019)

Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network
por: Gaggiano, Carla, et al.
Publicado: (2021)

PReS-FINAL-2199: A novel mutation in the CIAS1/NLRP3 gene associated with an unusual phenotype of CAPS
por: Insalaco, A, et al.
Publicado: (2013)

PReS-FINAL-2359: Renal involvement in hypocomplementemic urticarial vasculitis syndrome (huvs): report of 3 paediatric cases
por: Bracaglia, C, et al.
Publicado: (2013)

Clinical profile and evolution of patients with juvenile-onset Behçet’s syndrome over a 25-year period: insights from the AIDA network
por: Sota, Jurgen, et al.
Publicado: (2021)

Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept
por: Verazza, Sara, et al.
Publicado: (2016)

PReS-FINAL-2096: Herpes virus infections in patients with juvenile idiopathic arthritis (JIA) treated with etanercept
por: Nicolai, R, et al.
Publicado: (2013)

Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network
por: Vitale, Antonio, et al.
Publicado: (2021)

When flexibility is not necessarily a virtue: a review of hypermobility syndromes and chronic or recurrent musculoskeletal pain in children
por: Cattalini, Marco, et al.
Publicado: (2015)

Update on the Medical Management of Gastrointestinal Behçet's Disease
por: Lopalco, Giuseppe, et al.
Publicado: (2017)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

PReS-FINAL-2142: Predictors of persistent remission following etanercept (ETN) withdrawal in patients with juvenile idiopathic arthritis (JIA)
por: Perfetti, F, et al.
Publicado: (2013)

Off-label use of canakinumab in pediatric rheumatology and rare diseases
por: Del Giudice, Emanuela, et al.
Publicado: (2022)

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
por: Fabiani, Claudia, et al.
Publicado: (2020)

High prevalence of rare FBLIM1 gene variants in an Italian cohort of patients with Chronic Non-bacterial Osteomyelitis (CNO)
por: d’Adamo, Adamo Pio, et al.
Publicado: (2020)

Clinical presentation and cytokine production abnormalities in a cohort of patients carrying NLRP12 gene variants
por: Insalaco, Antonella, et al.
Publicado: (2014)

Childhood multisystem inflammatory syndrome associated with COVID-19 (MIS-C): a diagnostic and treatment guidance from the Rheumatology Study Group of the Italian Society of Pediatrics
por: Cattalini, Marco, et al.
Publicado: (2021)

Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)
por: Vitale, Antonio, et al.
Publicado: (2023)

Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis
por: Simonini, Gabriele, et al.
Publicado: (2013)

The interferon-gamma pathway is selectively up-regulated in the liver of patients with secondary hemophagocytic lymphohistiocytosis
por: Prencipe, Giusi, et al.
Publicado: (2019)

Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases
por: Gaggiano, Carla, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jkhmm26jnqvrjq27cce2juahne